Catalent to Acquire Pharmatek

Catalent, the world’s number one drug development, delivery and supply partner for drugs, biologics and consumer health products has announced its plans to acquire San Diego based Pharmatek Laboratories.  This planned acquisition will add discovery-to-clinic development capabilities, expand its capability for handling highly potent compounds and add spray drying to its technologies.

The acquisition to acquire Pharmatek is planned to close in the next few weeks, enhancing Catalent’s existing technologies and network while expanding their West Coast presence.

Read More